I don't think personally that the report due tomorrow is going to be a pps catalyst without follow up news on detailed reasons for dilution, progress made to date with NTEK and NTGL, and business plan going forward. FY 2016 revenues missed the $70 million projections by over $50 million. So don't panic if report doesn't meet expectations. Its what the company plans to do FY 2017 that will be factor going forward. PPS may fall providing another buying opportunity in short run. I think Qtr 2 ending Dec 31st will be important indicator of health of company.